Axomap

The Programmable Plant Stack Signals

18 Companies 3 Categories
Connect landscape data to View landscape

Clear applications and early buyer validation are visible across the landscape. Repeatable commercial demand is not yet broadly demonstrated across independent providers.

ConfidenceMedium

Assessed as of

Current state, informed by 36 months and relevant older history.

Supporting sources (12)

Competitive strength is spread across providers addressing distinct plant design needs. No clear leading group dominates the landscape overall.

ConfidenceLow

Assessed as of

Current structure, informed by 24 months.

Supporting sources (15)

Substantive change is occurring across several independent providers. Commercial deployment is advancing alongside broader plant design capabilities.

ConfidenceMedium

Assessed as of

Rolling six months; no acceleration score.

Supporting sources (9)

Overall venture funding remains broadly comparable with the preceding year. Investment has shifted between categories rather than strengthened consistently across the landscape.

ConfidenceMedium

Assessed as of

Rolling 12 months versus the preceding 12 months.

Supporting sources (7)

Plant design capabilities are broadening into additional practical applications. The expansion extends across breeding, editing and ingredient production.

ConfidenceMedium

Assessed as of

Rolling 12 months.

Supporting sources (10)

Independent participation is broadly stable across the landscape, with no clear expansion or consolidation trend.

ConfidenceLow

Assessed as of

Rolling 24 months.

Supporting sources (3)

AI trait design & predictive breeding platforms

Buyer validation is visible across several independent providers. Adoption remains uneven, with much of the market still moving from crop development into commercial use.

ConfidenceMedium

Assessed as of

Current state, informed by 36 months and relevant older history.

Supporting sources (8)

Competitive strength is dispersed across providers serving different crop and breeding needs. No clear leading group has demonstrated broad commercial dominance.

ConfidenceLow

Assessed as of

Current structure, informed by 24 months.

Supporting sources (7)

Substantive change is occurring across several independent providers. Commercial deployment is advancing while the market also gains broader analytical capabilities.

ConfidenceMedium

Assessed as of

Rolling six months; no acceleration score.

Supporting sources (6)

Venture investment has weakened in monetary strength despite reaching a slightly broader set of recipients. The decline is driven by a much smaller volume of dollar funding.

ConfidenceMedium

Assessed as of

Rolling 12 months versus the preceding 12 months.

Supporting sources (5)

Products are broadening into additional crop applications and deeper genomic analysis. Trait design is extending toward a wider range of practical breeding uses.

ConfidenceMedium

Assessed as of

Rolling 12 months.

Supporting sources (5)

Independent participation appears broadly stable, with no clear evidence that entry or consolidation is changing the category.

ConfidenceLow

Assessed as of

Rolling 24 months.

Supporting sources (1)
Company Score Movement History
63 —
58 —
52 —
48 —
47 —

Genome editing & "trait delivery" platforms

Editing platforms have clear applications and external buyer validation across multiple providers. Broad, repeatable commercial adoption remains unproven.

ConfidenceMedium

Assessed as of

Current state, informed by 36 months and relevant older history.

Supporting sources (6)

A small group has substantially stronger demonstrated external adoption than the less commercially validated providers. Competitive strength appears unevenly distributed.

ConfidenceLow

Assessed as of

Current structure, informed by 24 months.

Supporting sources (9)

Meaningful change is localized around broader access to an existing editing platform. The recent developments do not demonstrate change across a broad set of independent providers.

ConfidenceLow

Assessed as of

Rolling six months; no acceleration score.

Supporting sources (3)

Venture investment increased substantially from the preceding period. The increase is concentrated rather than spread across multiple recipients.

ConfidenceMedium

Assessed as of

Rolling 12 months versus the preceding 12 months.

Supporting sources (1)

Editing platform applications are broadening into additional crop uses. Integration into crop editing services is also extending how existing capabilities can be delivered.

ConfidenceLow

Assessed as of

Rolling 12 months.

Supporting sources (4)

Independent participation appears broadly stable, with no clear evidence of genuine entry or consolidation changing the category.

ConfidenceLow

Assessed as of

Rolling 24 months.

Supporting sources (3)
Company Score Movement History
68 —
66 —
26 +26
14 —
0 —

Plant molecular farming & biofactories

Plant production of functional ingredients is moving toward commercial supply, with early buyer validation. Repeatable demand across independent providers is not yet broadly demonstrated.

ConfidenceLow

Assessed as of

Current state, informed by 36 months and relevant older history.

Supporting sources (3)

Several independent providers are pursuing plant production of ingredients, without a clearly established commercial leading group.

ConfidenceLow

Assessed as of

Current structure, informed by 24 months.

Supporting sources (5)

Few meaningful market developments are visible in the latest six months.

ConfidenceLow

Assessed as of

Rolling six months; no acceleration score.

Supporting sources (3)

Observed venture funding has declined from a small prior period base to no verified funding in the latest year.

ConfidenceLow

Assessed as of

Rolling 12 months versus the preceding 12 months.

Supporting sources (1)

Ingredient capabilities are broadening beyond the initial dairy protein focus into additional nutrition applications.

ConfidenceLow

Assessed as of

Rolling 12 months.

Supporting sources (1)

Independent participation appears broadly stable, with no clear evidence of genuine entry or consolidation changing the category.

ConfidenceLow

Assessed as of

Rolling 24 months.

Supporting sources (3)
Company Score Movement History
33 —
31 —
21 +21